Cart
sales@molnova.com
Disomotide
CAS No. 181477-43-0
Disomotide( —— )
Catalog No. M21179 CAS No. 181477-43-0
Disomotide is an oligopeptide for the treatment of melanoma.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDisomotide
-
NoteResearch use only, not for human use.
-
Brief DescriptionDisomotide is an oligopeptide for the treatment of melanoma.
-
DescriptionDisomotide is an oligopeptide for the treatment of melanoma.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorothers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number181477-43-0
-
Formula Weight1035.2
-
Molecular FormulaC47H74N10O14S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCC(C)C(N)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)NC(C(=O)O)C(C)C)C(C)C
-
Chemical Name(3S6S9S12S15S)-15-amino-3-(((S)-5-amino-1-(((S)-1-((S)-2-(((S)-1-carboxy-2-methylpropyl)carbamoyl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)amino)-15-dioxopentan-2-yl)carbamoyl)-9-((S)-sec-butyl)-12-(hydroxymethyl)-6-(2-(methylthio)ethyl)-581114-tetraoxo-16-phenyl-471013-tetraazahexadecanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bayes M Rabasseda X Prous J R . Gateways to Clinical Trials[J]. methods & findings in experimental & clinical pharmacology 2008 30(4):313.
molnova catalog
related products
-
Peptide YY(3-36), PY...
Peptide YY (PYY) (3-36), Human is an endogenous appetite suppressing peptide. Peptide YY (PYY) (3-36), Human, a neuropeptide Y (NPY) Y2 receptor agonist, is a powerful inhibitor of intestinal secretion.
-
Exo1
Exo1 is a chemical inhibitor of the exocytic pathway.
-
Stressin I
Potent and selective corticotropin releasing factor receptor-1 (CRF1) agonist (Ki values are 1.5 and 224 nM for CRF1 and CRF2 receptors respectively). Increases ACTH levels and increases faecal pellet output in vivo following i.p. administration.
